MLAB Quote, Financials, Valuation and Earnings

Technicals

Company Profile

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Stock Forecast FAQ

In the current month, MLAB has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The MLAB average analyst price target in the past 3 months is $104.50.

• Where Will Mesa Laboratories, Inc. Stock Be In 1 Year?

  According to analysts, the consensus estimate is that Mesa Laboratories, Inc. share price will rise to $104.50 per share over the next 12 months.

• What Do Analysts Say About Mesa Laboratories, Inc.?

  Analysts are divided on their view about Mesa Laboratories, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mesa Laboratories, Inc. is a Sell and believe this share price will drop from its current level to $94.00.

• What Is Mesa Laboratories, Inc.'s Price Target?

  The price target for Mesa Laboratories, Inc. over the next 1-year time period is forecast to be $104.50 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

• Is MLAB A Buy, Sell Or Hold?

  According to Wall Street analysts, the consensus rating for Mesa Laboratories, Inc. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.

• How Can I Buy Shares Of MLAB?

  You can purchase shares of Mesa Laboratories, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mesa Laboratories, Inc. shares.

• What Is The Mesa Laboratories, Inc. Share Price Today?

  Mesa Laboratories, Inc. was last trading at $89.93 per share. This represents the most recent stock quote for Mesa Laboratories, Inc.. Yesterday, Mesa Laboratories, Inc. closed at $90.59 per share.

• How To Buy Mesa Laboratories, Inc. Stock Online?

  In order to purchase Mesa Laboratories, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

Related Companies

• Cognex Corp.
• Sono-Tek Corp.